What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Cell Rep. 2021 Sep 7;36(10):109685. doi: 10.1016/j.celrep.2021.109685. Cell Rep. 2021. PMID: 34496257
.
. Item in Clipboard